The aim of the study was to evaluate the presence of Mycoplasma bovis infection and co-infections with other Mycoplasma spp. infections in cattle. The tested population was one in the eastern region of Poland containing 66 dairy cows and 23 calves showing different clinical signs and suffering from pneumonia, mastitis, and arthritis. The incidence of M. bovis in co-infections with other Mycoplasma spp. was examined using serological traditional mycoplasma culture methods, and the molecular methods -PCR and polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE). The PCR/DGGE method for detecting Mycoplasma spp. in cattle was used for the first time in Poland. The seroprevalence of M. bovis in the affected cattle herds in the eastern region of Poland was 47.8% in calves and 19.7% in dairy cows. The direct detection and identification of M. bovis from nasopharyngeal swabs by PCR revealed that 56.5% of calves were positive, but all of the dairy cows were negative. The PCR/DGGE identified eight (34.8%) instances of M. arginini and eight (26.1%) instances of M. bovirhinis co-infecting with M. bovis in ten calves. The seroprevalence of M. bovis in the tested population was 33.7%. Any future attempts to control mycoplasma infections require an insight into the current epidemiological situation of M. bovis infection and its relationship to other mycoplasmas in causing clinical disease in cattle. Using these diagnostic methods we have demonstrated that mycoplasmal infections are often caused by multiple species of Mycoplasma and not just the primary M. bovis pathogen.
Introduction
Bovine respiratory infectious diseases frequently have multifactorial aetiology. Bovine respiratory viruses (bovine respiratory syncytial virus, bovine herpesvirus type 1, bovine viral diarrhoea virus, and parainfluenza virus type 3) as well as conventional bacteria (Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni) may all be contributing factors. Bovine (2, 6 -8, 10, 13, 16) . In Europe, M. bovis is believed to be responsible for 25% to 33% of calf pneumonia cases (12) . M. bovis-associated pneumonia may occur in cattle at different ages, including dairy cows, beef cattle, feedlot animals, and adults, especially after transport stress. Pneumonic clinical signs are nonspecific and include fever, cough, tachypnea, dyspnea, and decreased appetite, with or without nasal discharge (1, 15) . The co-infection of M. bovis with other causative organisms can increase the severity of respiratory disease in calves, as well as morbidity and mortality rates (9) , leading to a severe form of calf pneumonia, BRD, which is one of the most important problems in young cattle and inflicts high losses on the cattle industry (17) . In addition to respiratory disease, M. bovis can also cause clinical disease with pathological changes in the mammary gland, joints, conjunctival sac, and ears (5, 13, 20) . M. bovis infection is problematic to resolve, as a vaccine against the infection is currently not commercially available in Europe. In addition, more and more strains are acquiring antibiotic resistance (4, 5, 13) .
The aim of this study was to evaluate the epidemiological situation of M. bovis and concurrent mycoplasma infections in the affected cattle from the eastern region of Poland using complex diagnostic analysis consisting of serology, culture, and molecular testing. The PCR/DGGE was used for the first time in Poland for the detection of concurrent mycoplasma infections in cattle (11) .
Material and Methods
Animals. This study was performed on 89 cattle which included 23 two-month-old Black and White breed calves derived from three herds having 35-60 calves and 66 adult Holstein-Friesian cows from a herd of 120 in the Lubelskie Province (eastern Poland) with an average milk yield of 6500 kg. Nasopharyngeal swabs and sera were collected from all animals and 54 milk samples pooled from each quarter were collected from the dairy cows during 2014.
Serological and antigenic testing. The blood samples were collected from the vena jugularis externa and then centrifuged to obtain sera and stored at 4ºC for a maximum 48 h before testing for M. bovis antibodies using the indirect sandwich ELISA (Bio-X Diagnostics, Belgium). Positive or negative results with an evaluation of positivity degree (from 0 to 4+) were calculated according to the manufacturer's instructions.
Nasopharyngeal swabs were taken from all animals from the affected herds: the M. bovis seropositive cattle and asymptomatic animals in the herds. The swabs were placed in transport medium and kept at 4°C until the analysis, which was done within 24 h. The initial detection and identification of M. bovis was performed using the antigenic direct ELISA (Pulmotest, Bio-X Diagnostics, Belgium). Positive or negative results in this test were calculated according to the manufacturer's instructions, using the quality control sheet provided with the kit. Mycoplasma spp. were isolated by culturing in Eaton's broth and on Eaton's agar plates, and incubated at 37ºC with 5% CO2 (14) . Plates and broths were incubated for up to 21 d. The broths were observed for typical mycoplasma swirls of growth, for film formation on the surface of broth, and for any colour change, which may be from red to orange for the non-glucose fermenting Mycoplasma spp. such as M. bovis, or to yellow for glucose fermenters such as M. bovirhinis. If mycoplasma-like colonies appeared, DNA was extracted using the QIAmp DNA Mini Kit (Qiagen, Germany) and an M. bovis specific PCR was performed (18) . In addition the PCR/DGGE method following Eaton's broth enrichment (11) was used to detect mixed Mycoplasma spp. infections.
Milk samples were collected from all quarters from cows with clinical signs of mastitis or arthritis and were stored at 4ºC for a maximum of 24 h until being tested. A 100 µL sediment from 1 mL of centrifuged milk was cultured for mycoplasmas in Eaton's medium (14) . Antibody testing of milk samples used the indirect sandwich ELISA (Bio-X Diagnostics, Belgium). DNA extraction and molecular testing was as described for the nasopharyngeal swabs.
Molecular testing. The method used was an M. bovis specific PCR with the use of primers for the uvrC gene in a total reaction volume of 50 µL (18) . Using a T-personal thermocycler (Biometra, Germany), the conditions for the PCR were as follows: initial denaturation at 95ºC for 5 min, followed by 33 cycles of denaturation at 94ºC for 30 s, annealing of primers at 60ºC for 30 s, extension at 72ºC for 90 s, and a final extension step of 72ºC for 7 min. Samples were kept at 4ºC until analysis. PCR products were analysed on 2% agarose gels stained with ethidium bromide and visualised under UV light by digital camera. The procedure was modified from that described by Subramaniam et al. (18) because slightly different annealing and extension temperatures and times were used. The procedure was validated for the use at the NVRI laboratory using 16 control samples of different Mycoplasma spp. and other bacteria species for specificity testing and M. bovis strain ATCC 25523™ for sensitivity testing. Sequencing of the uvrC gene fragment was performed on a GS FLX/Titanum sequencer (Roche, USA), supplied by GENOMED (Poland).
The DGGE method was used as described by McAuliffe et al. (11) with modifications. The method is based on the prevention of migration of DNA fragments following strand separation caused by chemical denaturants. Each Mycoplasma spp. forms characteristic "fingerprinting" in the gel lane. This enables the detection and differentiation of 67 Mycoplasma spp. of veterinary importance. Amplification was performed with a GC-341 primer specific for bacteria and MYC-543 as the second primer, which is mollicute-specific; both primers are based on the V3 region of 16S rDNA gene. Samples were kept at 4ºC until analysis. PCR products were checked for correct amplification by electrophoresis on a 2% agarose gel stained with ethidium bromide under UV illumination. The PCR/DGGE was performed using the DCode Universal Mutation Detection System (Bio-Rad, USA). The PCR products were separated by loading onto 10% polyacrylamide/bis (37.5:1) gels with denaturing gradients from 25% to 60% (where 100% is 7 M urea and 40% (v/v) deionised formamide) in 1 × Tris, acetic acid, and EDTA (TAE) electrophoresis buffer (EurX, Poland). Electrophoresis was performed for 19 h at 100 V at 60ºC. For the product visualisation, gels were stained with SYBR Gold (Life Technologies, USA) in 1 × TAE for 30 min and restained in distilled water for 30 min at room temperature, visualised under UV, and stored as a digital image (11) .
Statistical analysis. Statistical analyses of various parameters were performed using Statistica 8.0 (Statsoft, USA) software. The correlation between the observed clinical signs of M. bovis infection and the results of serological, cultivation, and PCR testing was determined by Spearman's rank correlation coefficient (nonparametric). The differences with α < 0.05 were considered as significant.
Results
Eighty-nine cattle from four farms situated in the Lubelskie Province (eastern part of Poland), showing clinical signs suggestive of mycoplasma infection, were included in the study. The clinical signs were characteristic of pneumonia, mastitis, and arthritis. Nasal discharge, fever, cough, dyspnea, apathy, lack of appetite, high somatic cell counts, swollen udder and joints, and decreased level of milk production were observed. As many as 87% of the examined calves had clinical signs indicating the possibility of M. bovis infection, whilst the percentage was lower (21.2) in the adult cattle.
The results of serological examinations using an indirect ELISA, irrespective of cattle age, indicated widespread exposure to M. bovis infection with 33.7% being seropositive by either milk or sera. Calves had more seropositive results. Eleven (47.8%) calves were positive, with seven (30.4%) animals determined as highly positive (≥ 2+) (Fig. 1) . In the dairy cows only seven (10.6%) serum samples and 16 (29.6%) milk samples were seropositive for M. bovis antibodies (Fig. 2) .
In the calves, M. bovis antigen was directly detected in 11 nasopharyngeal swabs from 23 (47.8%) animals by the antigenic direct ELISA, whereas the direct isolation and identification of M. bovis by culturing in Eaton's medium and classical PCR testing gave 13 (56.5%) positive results ( (Table 2) .
In 55 of the 89 animals examined, there were no clinical signs or evidence of mycoplasma infection, as confirmed by a range of methods used in this study. The rest of the animals (38%) showed clinical signs including pneumonia, mastitis, or arthritis, which may be characteristic of M. bovis infection. Among them the most severely affected calves displayed pneumonia, often with nasal discharge, cough, dyspnea, apathy, and lack of appetite. Some calves also had arthritis. The most severely affected calves were found to have mixed infections of M. bovis, M. bovirhinis, and M. arginini. In the dairy cattle affected with mastitis and arthritis, swollen udders and joints, fever (average temperature about 39.9ºC), dramatically decreased yield and quality of milk, and in some severe cases atrophy of affected quarters were observed. Sporadically, a decrease in milk production in some affected cows was also connected with warm, painful, and swollen carpal and tarsal joints (Tables 1 and 3) . The clinical forms of mycoplasmal mastitis were often non-responsive to routinely used antibiotic therapy. Positive correlation was found between the observed clinical signs of M. bovis infection and the serological results in the group of dairy cows (R-Spearman = 0.65, P < 0.05). In the group of calves, positive correlation between the clinical signs of the infection and PCR results (R-Spearman = 0.44, P < 0.05), as well as between serological and cultivation results (R-Spearman = 0.37, P > 0.05) was found. 
Discussion
Many of the cattle studied had clinical signs which were specific for mycoplasma infections, and in the current study we either detected antibodies to M. bovis or DNA to a number of Mycoplasma species. These results unequivocally confirmed M. bovis infection in these cattle herds situated in the Lubelskie Province.
Generally, serological investigation demonstrates previous exposure to infection, in this case mycoplasma infection, but it does not confirm current infection. Mycoplasma culture is a difficult and time-consuming process, as the mycoplasmas can be very fastidious, whereas the use of molecular testing enables the DNA detection of live and inactivated microorganisms. Clinical observation is not sufficient to diagnose Mycoplasma infections so infection or disease needs to be confirmed using laboratory methods. Here we have demonstrated that a combination of serological, molecular, and microbiological techniques are the best to diagnose Mycoplasma infections. However, in several cases the serological result does not match with the detection of the organism. For example, calf no. 3 had a 3+ M. bovis serological result, but only M. bovirhinis was detected; in contrast, calf no. 10 had M. bovis and M. arginini detected but was serologically negative. This may be due to the sensitivity and specificity of the serological test, the stage of infection and the antibody response, or the nasopharyngeal swab sampling, where organisms are only intermittently shed. It may be that bronchoalveolar lavage sampling would improve the detection rate of Mycoplasma species when compared with testing nasopharyngeal swabs (19 (10) claim that according to their research the most mycoplasmas were effectively isolated from nasal swabs and not from milk samples. Therefore it can suggest that results of our study are more compatible with those obtained in other European countries using the same methods for M. bovis detection. It has been reported that some mycoplasmas can occur in different countries with different prevalence according to local epidemiological situation (3, 6, 10) .
In conclusion, M. bovis seroprevalence in the tested cattle population was 33.7%. We gleaned additional information that mycoplasma infection is often caused by multiple species of Mycoplasma and not just as the primary M. bovis pathogen. There is a need to assess mycoplasma infections and the current epidemiological situation of M. bovis infection and its relationship to other mycoplasmas causing clinical disease in cattle.
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